[go: up one dir, main page]

FI860153L - Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning. - Google Patents

Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning. Download PDF

Info

Publication number
FI860153L
FI860153L FI860153A FI860153A FI860153L FI 860153 L FI860153 L FI 860153L FI 860153 A FI860153 A FI 860153A FI 860153 A FI860153 A FI 860153A FI 860153 L FI860153 L FI 860153L
Authority
FI
Finland
Prior art keywords
deras
oligopeptider
mellanprodukter
foerfarande foer
framstaellning
Prior art date
Application number
FI860153A
Other languages
English (en)
Other versions
FI86547C (fi
FI860153A0 (fi
FI86547B (fi
Inventor
Hendrik Simons Jansz
Cornelis Josephus Maria Lips
Paul Herman Steenbergh
Hans Rink
Peter Sieber
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI860153A0 publication Critical patent/FI860153A0/fi
Publication of FI860153L publication Critical patent/FI860153L/fi
Application granted granted Critical
Publication of FI86547B publication Critical patent/FI86547B/fi
Publication of FI86547C publication Critical patent/FI86547C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57527—Calcitonin gene related peptide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI860153A 1985-01-16 1986-01-13 Foerfarande foer framstaellning av en peptid som verkar farmakologiskt pao hjaercirkulationen eller skelettaemnesomsaettningen. FI86547C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH18885 1985-01-16
CH18885 1985-01-16

Publications (4)

Publication Number Publication Date
FI860153A0 FI860153A0 (fi) 1986-01-13
FI860153L true FI860153L (fi) 1986-07-17
FI86547B FI86547B (fi) 1992-05-29
FI86547C FI86547C (fi) 1992-09-10

Family

ID=4181264

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860153A FI86547C (fi) 1985-01-16 1986-01-13 Foerfarande foer framstaellning av en peptid som verkar farmakologiskt pao hjaercirkulationen eller skelettaemnesomsaettningen.

Country Status (12)

Country Link
US (1) US4720483A (fi)
EP (1) EP0188400B1 (fi)
JP (1) JPH0780908B2 (fi)
AT (1) ATE78040T1 (fi)
CA (1) CA1339365C (fi)
DE (1) DE3685885D1 (fi)
DK (1) DK17986A (fi)
ES (2) ES8707974A1 (fi)
FI (1) FI86547C (fi)
GR (1) GR860081B (fi)
IE (1) IE58190B1 (fi)
PT (1) PT81837B (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221518A (en) * 1984-12-14 1993-06-22 Mills Randell L DNA sequencing apparatus
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
DE3888357T2 (de) * 1987-06-22 1994-09-15 Merck & Co Inc Cyclosporin-Derivate, die eine modifizierte Aminosäure auf Stellung 8 tragen.
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5153308A (en) * 1988-06-16 1992-10-06 Teijin Limited S-sulfonated calcitonin derivatives
US5175145A (en) * 1988-08-26 1992-12-29 Amylin Pharmaceuticals, Inc. Treatment of diabetes mellitus with amylin agonists
GB8829432D0 (en) * 1988-12-15 1989-02-01 Celltech Ltd Enzymatic process
EP0448513A3 (en) * 1990-03-21 1991-12-27 Japat Ltd Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
JPH06510281A (ja) * 1991-08-08 1994-11-17 アミリン・ファーマシューティカルズ，インコーポレイテッド ペプチドアミドの製造
US5569604A (en) * 1993-09-03 1996-10-29 The University Of Iowa Research Foundation Calcitonin/calcitonin gene related peptide enhancer element and associated DNA binding proteins
US5898031A (en) * 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7812149B2 (en) * 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US20050053976A1 (en) * 1996-06-06 2005-03-10 Baker Brenda F. Chimeric oligomeric compounds and their use in gene modulation
US20040147022A1 (en) * 1996-06-06 2004-07-29 Baker Brenda F. 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations
US20050119470A1 (en) * 1996-06-06 2005-06-02 Muthiah Manoharan Conjugated oligomeric compounds and their use in gene modulation
US20040171031A1 (en) * 1996-06-06 2004-09-02 Baker Brenda F. Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US20050042647A1 (en) * 1996-06-06 2005-02-24 Baker Brenda F. Phosphorous-linked oligomeric compounds and their use in gene modulation
US20040203024A1 (en) * 1996-06-06 2004-10-14 Baker Brenda F. Modified oligonucleotides for use in RNA interference
WO2005121371A2 (en) * 2004-06-03 2005-12-22 Isis Pharmaceuticals, Inc. Double strand compositions comprising differentially modified strands for use in gene modulation
US6042848A (en) * 1996-08-15 2000-03-28 The Board Of Trustees Of Southern Illinois University Enhancement of antimicrobial peptide activity by metal ions
DE19652033A1 (de) * 1996-12-13 1998-06-18 Irmgard Dr Med Guertner Neuropeptid (CGRP) als Modulator zur Zelldifferenzierung und Proliferation
AU2003290598A1 (en) * 2002-11-05 2004-06-03 Isis Pharmaceuticals, Inc. Modified oligonucleotides for use in rna interference
EP1636342A4 (en) * 2003-06-20 2008-10-08 Isis Pharmaceuticals Inc OLIGOMER COMPOUNDS FOR USE IN THE MODULATION OF GENES
WO2005067890A2 (en) * 2004-01-13 2005-07-28 Vasogenix Pharmaceuticals, Inc. Controlled release cgrp delivery composition for cardiovascular and renal indications
US20090023644A1 (en) * 2004-01-13 2009-01-22 Southard Jeffery L Methods of using cgrp for cardiovascular and renal indications
EP1703916A2 (en) * 2004-01-13 2006-09-27 Vasogenix Pharmaceuticals, Inc. Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same
US8569474B2 (en) * 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) * 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) * 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
JP4884193B2 (ja) * 2006-12-15 2012-02-29 ヤマハ発動機株式会社 船舶
US8835379B2 (en) 2009-10-30 2014-09-16 Novo Nordisk A/S Derivatives of CGRP
JP2014524264A (ja) * 2011-08-22 2014-09-22 スガニット・システムズ・インコーポレーテッド バイオブタノールおよび関連する生成物の製造
WO2025196129A1 (en) * 2024-03-19 2025-09-25 Epoqe Pharma Aps Calcitonin gene-related peptide analogues

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE134631T1 (de) * 1983-06-15 1985-12-05 Roger Kingdom Craig Peptide, pharmazeutische zusammensetzungen, gene, vektoren, wirtorganismen, verfahren zu deren herstellung und diagnostische reagenzien.
US4530838A (en) * 1983-07-08 1985-07-23 The Salk Institute For Biological Studies Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
GB8327346D0 (en) * 1983-10-12 1983-11-16 Morris H R Peptide
US4549986A (en) * 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP

Also Published As

Publication number Publication date
IE58190B1 (en) 1993-07-28
US4720483A (en) 1988-01-19
JPH0780908B2 (ja) 1995-08-30
PT81837B (pt) 1988-05-27
FI86547C (fi) 1992-09-10
ES8707974A1 (es) 1987-09-01
ES550911A0 (es) 1987-09-01
ES557315A0 (es) 1988-04-01
GR860081B (en) 1986-04-29
DK17986A (da) 1986-07-17
IE860116L (en) 1986-07-16
ES8802161A1 (es) 1988-04-01
DE3685885D1 (de) 1992-08-13
PT81837A (en) 1986-02-01
CA1339365C (en) 1997-08-26
EP0188400A3 (en) 1988-08-31
FI860153A0 (fi) 1986-01-13
EP0188400A2 (de) 1986-07-23
JPS61172899A (ja) 1986-08-04
ATE78040T1 (de) 1992-07-15
DK17986D0 (da) 1986-01-15
EP0188400B1 (de) 1992-07-08
FI86547B (fi) 1992-05-29

Similar Documents

Publication Publication Date Title
FI860232A0 (fi) Tiazolidindionderivat, deras framstaellning och anvaendning.
FI860832A7 (fi) Tiazolidinderivat, deras framstaellning och anvaendning.
FI862644A7 (fi) Tiazoler, deras framstaellning och dessa innehaollande farmaceutiska foereningar.
FI863786L (fi) Mikrocellulaera, energihaltiga kompositmaterialer och foerfarande foer deras framstaellning.
FI870012A0 (fi) Medelst kopplingsreaktion erhaollna fosforhaltiga amider, deras prekursorer och dessa innehaollande smoerjmedelkompositioner.
FI860153L (fi) Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning.
FI860265L (fi) Anvaendning av en fibervaev innefattande mikrosfaerer foer tillverkning av foerstaerkta foeremaol, foerstaerkta foeremaol och saett foer tillverkning av en fibervaev innefattande mikrosfaerer.
FI863097L (fi) Absorberande stomme avsedd foer engaongsartiklar saosom bloejor, sanitetsbindor och dylika.
FI862029A0 (fi) Askorbinsyraderivat, deras framstaellning och anvaendning.
FI863041L (fi) Fusionsprotein, foerfarande foer deras framstaellning och deras anvaendning.
FI862727L (fi) Vattenbaserade, av flere komponenter bestaoende polymerkompositioner och foerfarande foer framstaellning av dessa.
FI861683A7 (fi) N-indolyletyl-sulfonsyra-amider, foerfarande foer deras framstaellning och deras anvaendning.
FI863661A0 (fi) Benzimidazolderivat, deras framstaellning och terapeutiska anvaendning.
FI863798L (fi) Tvaettmedel innehaollande polyeterkarbonsyraderivat, deras framstaellning och anvaendning.
FI862374A0 (fi) Foerfarande och anordning foer rundning av plaot, saerskilt foer doskroppar.
FI865264A0 (fi) Foerfarande foer anvaendning av en spektralskiftskaernreaktor och en kaernreaktor, i vilken anvaends vatten undantraengande knippen.
FI870734L (fi) Magnetiskt oevervakningssystem foer foeremaol, foerfarande och kodad markoer.
FI861407A7 (fi) Kontaktanordning foer avskaermade kabiner och utrymmen med hoegfrekvensskaermade, relativt varandra roerliga hoeljesdelar.
FI864636L (fi) Taetningsdelar, foerslutningar och behaollare.
FI862691A0 (fi) 2-oxy-4h-3,1-benzoxazin-4-on-derivat och deras foereningar.
FI860199A7 (fi) Tricykliska foereningar, dessa innehaollande kompositioner, foerfarande foer deras framstaellning och vaordfoerfarande medelst anvaendning av dessa.
FI863365L (fi) Indolinonderivat, foerfarande foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI862478A0 (fi) Vattenbaserade, filmbildande oeverdragskompositioner och deras anvaendning.
FI863480A0 (fi) Azolyl-cyklopropyl-etanolderivat, foerfarande foer deras framstaellning och deras anvaendning.
FI860121A7 (fi) Foerfarande och anordning foer loesbrytning av avlagring och murverk i liggande cylindrar, saerskilt i roterugnar.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: CELLTECH LIMITED

MM Patent lapsed
MM Patent lapsed

Owner name: CELLTECH LIMITED